![]() 9H-Xanthen-9-one, 3,4,5,6-tetrahydroxy结构式
![]() |
常用名 | 9H-Xanthen-9-one, 3,4,5,6-tetrahydroxy | 英文名 | 9H-Xanthen-9-one, 3,4,5,6-tetrahydroxy |
---|---|---|---|---|
CAS号 | 99420-08-3 | 分子量 | 260.19900 | |
密度 | 1.766±0.06 g/cm3 (20 °C, 760 mmHg) | 沸点 | 487.8±45.0 °C (760 mmHg) | |
分子式 | C13H8O6 | 熔点 | >340 °C (decomp) | |
MSDS | 中文版 美版 | 闪点 | N/A |
英文名 | 9H-Xanthen-9-one, 3,4,5,6-tetrahydroxy |
---|---|
英文别名 | 更多 |
密度 | 1.766±0.06 g/cm3 (20 °C, 760 mmHg) |
---|---|
沸点 | 487.8±45.0 °C (760 mmHg) |
熔点 | >340 °C (decomp) |
分子式 | C13H8O6 |
分子量 | 260.19900 |
精确质量 | 260.03200 |
PSA | 111.13000 |
LogP | 1.76860 |
9H-Xanthen-9-one, 3,4,5,6-tetrahydroxy上游产品 0 | |
---|---|
9H-Xanthen-9-one, 3,4,5,6-tetrahydroxy下游产品 1 | |
Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin.
J. Exp. Med. 197 , 725-33, (2003) Statins, known as inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, exhibit numerous functions related to inflammation, such as MHC class II down-regulation, interference with T... |
Xanthen-9-one, 3,4,5,6-tetrahydroxy- |
3,4,5,6-Tetrahydroxyxanthone hydrate |
3,4,5,6-Tetrahydroxy-9H-xanthen-9-one |